CANCER GENETICS, INC 4
4 · CANCER GENETICS, INC · Filed Dec 15, 2014
Insider Transaction Report
Form 4
El Naggar Jane Houldsworth
VP of Research and Development
Transactions
- Award
Stock Option (right to buy)
2014-12-11+10,000→ 10,000 totalExercise: $6.30Exp: 2024-12-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Options vest twenty percent on the date of grant, with subsequent vesting in equal installments over the following forty-eight months.